These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 37592151)

  • 1. METTL14 Suppresses Tumor Stemness and Metastasis of Colon Cancer Cells by Modulating m6A-Modified SCD1.
    Xu D; Han S; Yue X; Xu X; Huang T
    Mol Biotechnol; 2024 Aug; 66(8):2095-2105. PubMed ID: 37592151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL14-mediated N6-methyladenosine modification of SOX4 mRNA inhibits tumor metastasis in colorectal cancer.
    Chen X; Xu M; Xu X; Zeng K; Liu X; Pan B; Li C; Sun L; Qin J; Xu T; He B; Pan Y; Sun H; Wang S
    Mol Cancer; 2020 Jun; 19(1):106. PubMed ID: 32552762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyltransferase-like 14 suppresses growth and metastasis of renal cell carcinoma by decreasing long noncoding RNA NEAT1.
    Liu T; Wang H; Fu Z; Wang Z; Wang J; Gan X; Wang A; Wang L
    Cancer Sci; 2022 Feb; 113(2):446-458. PubMed ID: 34813676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.
    Xie Q; Li Z; Luo X; Wang D; Zhou Y; Zhao J; Gao S; Yang Y; Fu W; Kong L; Sun T
    J Transl Med; 2022 Jan; 20(1):51. PubMed ID: 35093098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.
    Yi D; Wang R; Shi X; Xu L; Yilihamu Y; Sang J
    Oncol Rep; 2020 May; 43(5):1375-1386. PubMed ID: 32323801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. METTL14 decreases FTH1 mRNA stability via m6A methylation to promote sorafenib-induced ferroptosis of cervical cancer.
    Li L; Zeng J; He S; Yang Y; Wang C
    Cancer Biol Ther; 2024 Dec; 25(1):2349429. PubMed ID: 38738555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. METTL14-mediated N
    Liu Z; Sun T; Piao C; Zhang Z; Kong C
    Cell Commun Signal; 2022 Mar; 20(1):36. PubMed ID: 35305660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N(6)-adenosine-methyltransferase-14 promotes glioma tumorigenesis by repressing argininosuccinate synthase 1 expression in an m6A-dependent manner.
    Miao YQ; Chen W; Zhou J; Shen Q; Sun Y; Li T; Wang SC
    Bioengineered; 2022 Jan; 13(1):1858-1871. PubMed ID: 35012429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N6-methyladenosine methylation on FSCN1 mediated by METTL14/IGF2BP3 contributes to human papillomavirus type 16-infected cervical squamous cell carcinoma.
    Tian Q; Huang J; Zhang Q; Zhao J
    Clin Exp Pharmacol Physiol; 2024 Jun; 51(6):e13864. PubMed ID: 38679464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. METTL14-mediated N6-methyladenosine modification of TCP1 mRNA promotes acute myeloid leukemia progression.
    Zhang M; Xie Z; Tan Y; Wu Y; Wang M; Zhang P; Yuan Y; Li J
    Cell Signal; 2024 Oct; 122():111304. PubMed ID: 39033992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
    Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
    Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. METTL14-Mediated Bim mRNA m6A Modification Augments Osimertinib Sensitivity in EGFR-Mutant NSCLC Cells.
    Fan S; Lv X; Zhang C; Zeng B; Liang Y; Chen D; Xu Z; Li P; Wu S; Liu H; Luo K; Liu Z; Yi Y
    Mol Cancer Res; 2024 Nov; 22(11):1051-1063. PubMed ID: 38953880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3 regulates m6A in endometrioid epithelial ovarian cancer independently of METTl14 and WTAP.
    Ma Z; Li Q; Liu P; Dong W; Zuo Y
    Cell Biol Int; 2020 Dec; 44(12):2524-2531. PubMed ID: 32869897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of METTL14 mediates the elevation of PERP mRNA N
    Wang M; Liu J; Zhao Y; He R; Xu X; Guo X; Li X; Xu S; Miao J; Guo J; Zhang H; Gong J; Zhu F; Tian R; Shi C; Peng F; Feng Y; Yu S; Xie Y; Jiang J; Li M; Wei W; He C; Qin R
    Mol Cancer; 2020 Aug; 19(1):130. PubMed ID: 32843065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL14 suppresses proliferation and metastasis of colorectal cancer by down-regulating oncogenic long non-coding RNA XIST.
    Yang X; Zhang S; He C; Xue P; Zhang L; He Z; Zang L; Feng B; Sun J; Zheng M
    Mol Cancer; 2020 Feb; 19(1):46. PubMed ID: 32111213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyltransferase like-14 suppresses growth and metastasis of non-small-cell lung cancer by decreasing LINC02747.
    Wang J; Wang S; Yang H; Wang R; Shi K; Liu Y; Dou L; Yu H
    Cancer Sci; 2024 Sep; 115(9):2931-2946. PubMed ID: 38888105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The m6A methyltransferase METTL14 inhibits the proliferation, migration, and invasion of gastric cancer by regulating the PI3K/AKT/mTOR signaling pathway.
    Liu X; Xiao M; Zhang L; Li L; Zhu G; Shen E; Lv M; Lu X; Sun Z
    J Clin Lab Anal; 2021 Mar; 35(3):e23655. PubMed ID: 33314339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. METTL14 benefits the mesenchymal stem cells in patients with steroid-associated osteonecrosis of the femoral head by regulating the m6A level of PTPN6.
    Cheng C; Zhang H; Zheng J; Jin Y; Wang D; Dai Z
    Aging (Albany NY); 2021 Dec; 13(24):25903-25919. PubMed ID: 34910686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. METTL14 regulates M6A methylation-modified primary miR-19a to promote cardiovascular endothelial cell proliferation and invasion.
    Zhang BY; Han L; Tang YF; Zhang GX; Fan XL; Zhang JJ; Xue Q; Xu ZY
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):7015-7023. PubMed ID: 32633395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. METTL14-Mediated m6A Modification of
    Gu X; Song Y; Liu X; Cheng Z; Min J; Zhang Y
    Front Biosci (Landmark Ed); 2024 Aug; 29(8):298. PubMed ID: 39206905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.